The Combination of the M2 Muscarinic Receptor Agonist and Chemotherapy Affects Drug Resistance in Neuroblastoma Cells

One of the major limits of chemotherapy is depending on the ability of the cancer cells to elude and adapt to different drugs. Recently, we demonstrated how the activation of the M2 muscarinic receptor could impair neuroblastoma cell proliferation. In the present paper, we investigate the possible e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucianò, Anna Maria, Perciballi, Elisa, Fiore, Mario, Del Bufalo, Donatella, Tata, Ada Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697391/
https://www.ncbi.nlm.nih.gov/pubmed/33182656
http://dx.doi.org/10.3390/ijms21228433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697391/
https://www.ncbi.nlm.nih.gov/pubmed/33182656
http://dx.doi.org/10.3390/ijms21228433

Ejemplares similares